HIGHLIGHTS
- who: Endocrine-Related and collaborators from the of Medicine and Health Technology, Tampere University and Tays Centre, Tampere University Hospital, Tampere, Finland have published the Article: Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen, in the Journal: (JOURNAL)
- what: By transcriptional characterization and comparison to the PCa cell lines LNCaP and LNCaPARhi, which mimic late-stage castration-resistant PCa, the authors show that the RWPE-1-AR cell line is useful as a nonmalignant, AR-positive prostate epithelial_cell model for studying the transformation of the prostate epithelium.
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.